PET/MRI Comparable to PET/CT in Staging Lung Cancer
PET/MR imaging offers comparable diagnostic image quality and tumor delineation in staging of lung cancer to PET/CT - with less radiation exposure.
PET plus MR imaging offers comparable diagnostic image quality and tumor delineation in staging of lung cancer to PET plus CT - with less radiation exposure to the patient, researchers reported in a study published in the journal Radiology.
Researchers from Eberhard-Karls University in Tübingen, Germany, studied 10 patients who were suspected to have or were diagnosed with bronchial carcinoma. The patients, aged 38 to 73, underwent fluorine 18 fluorodeoxyglucose (FDG) PET/CT, followed immediately by whole-body MR/PET imaging with a new hybrid whole-body system (3.0-T MR imager with integrated PET system).
Upon review of the results of the MR/PET, the researchers found nine of the 10 lesions showed pronounced FDG uptake. One lesion was morphologically suspicious for CT and MR imaging, but showed no FDG uptake.
Tumor-to-liver ratios were also calculated and compared between the two examinations. There was a significant correlation regarding the tumor-to-liver ratio with identical TNM scores for seven patients.
“MR/PET imaging of the lung is feasible and provides diagnostic image quality in the assessment of pulmonary masses,” the authors wrote. “Similar lesion characterization and tumor stage were found in comparing PET/CT and MR/PET images in most patients.”
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
